Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation
Bruno Dubois(Portland State University), Giovanni B. Frisoni(University of Geneva), Eric Widera(University of California, San Francisco), Agustín Ibáñez(Trinity College Dublin), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Stefano F. Cappa(Istituto Universitario di Studi Superiori di Pavia), Christopher C. Rowe(The University of Melbourne), Marc Agronin, Noll L. Campbell(Purdue University West Lafayette), Kaj Blennow(Sahlgrenska University Hospital), Sandra Swantek(American Association for Geriatric Psychiatry), Craig Ritchie(Western General Hospital), Nicolas Villain(Centre National de la Recherche Scientifique), Kristian Steen Frederiksen(University of Copenhagen), Howard Feldman(University of British Columbia), Leonardo Cruz de Souza(Universidade Federal de Minas Gerais), Jonathan M. Schott(UK Dementia Research Institute), Bernard Hanseeuw(Cliniques Universitaires Saint-Luc), Jennifer R. Gatchel(Harvard University), Paulo Caramelli(Universidade Federal de Minas Gerais), Lutz Froelich(Heidelberg University), Merçé Boada(Instituto de Salud Carlos III), Paul Newhouse(Vanderbilt University Medical Center), Douglas Galasko(University of California San Diego), Ricardo Nitríni(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), David T. Jones(Alzheimer’s Disease Neuroimaging Initiative), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), Frank Jessen(German Center for Neurodegenerative Diseases), Andrea Slachevsky(Universidad del Desarrollo), Andrea Bozoki(University of North Carolina at Chapel Hill), Ricardo Allegri(Instituto de Neurología Cognitiva), Madhav Thambisetty(National Institutes of Health), Helen Lavretsky(University of California, Los Angeles), Stéphanie Bombois(Université de Lille), Vincent Planche(Centre Hospitalier Universitaire de Bordeaux), Alexandre Bejanin(Hospital de Sant Pau), Agneta Nordberg(Karolinska Institutet), Alessandro Padovani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Miia Kivipelto(Karolinska University Hospital), Jean Georges(Alzheimer Europe), Lon S. Schneider(University of Southern California), Lisa Delano‐Wood(University of California San Diego), Richard Lévy(Télécom Paris), Gunhild Waldemar(University of Copenhagen)
Cited by 355
Related Papers
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k